Altitude Crest Partners’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-193,300	Closed	-$7.28M	–	17
2024 Q1	$7.28M	Buy	+193,300	New	+$7.28M	3.12%	10